Analyst Ranking
Bottom 2%
#4862 out of 4937 analysts
Average Return
-10.31%
Win Rate
28%46 out of 163
Risk vs Reward
Poor
Good

Michael Petusky's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Lifecore Biomedical IncLFCR
+131.94%$3.10$7.19
2023-03-19 -
2024-03-19
Buy
Opko Health IncOPK
+65.31%$0.99$1.63
2024-02-27 -
2025-02-27
Buy
Lifecore Biomedical IncLFCR
+54.15%$3.25$5.01
2023-03-20 -
2024-03-20
Buy
Lemaitre Vascular IncLMAT
+40.60%$71.06$99.91
2024-02-27 -
2025-02-27
Buy
Surmodics IncSRDX
+39.37%$30.10$41.95
2023-06-20 -
2024-06-20
Buy

Michael Petusky Analyst Color

Get additional color on Michael Petusky's coverage of popular stocks

Michael Petusky's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Haemonetics CorpHAE
18Buy$95.00+25.79%Maintains
a day ago
Option Care Health IncOPCH
16Buy$38.00+27.18%Maintains
2 days ago
U S Physical Therapy IncUSPH
18Buy$98.00+31.54%Maintains
11 days ago
Orthofix Medical IncOFIX
1Buy$16.00+44.80%Initiates Coverage On
19 days ago
Dentsply Sirona IncXRAY
16Buy$21.00+29.55%Maintains
2 months ago
Anika Therapeutics IncANIK
12Buy$19.00+68.59%Maintains
2 months ago
Henry Schein IncHSIC
14Buy$86.00+17.13%Maintains
2 months ago
Opko Health IncOPK
10Buy$2.25+66.67%Maintains
2 months ago
Merit Medical Systems IncMMSI
20Buy$103.00+10.17%Maintains
3 months ago
Verifyme IncVRME
9Buy$1.25+66.67%Maintains
4 months ago
Modivcare IncMODV
13Buy$6.00+86.92%Maintains
4 months ago
Lemaitre Vascular IncLMAT
8Buy$93.00+11.13%Maintains
8 months ago
Surmodics IncSRDX
5Buy$71.00N/AMaintains
a year ago
Lifecore Biomedical IncLFCR
9Buy$10.00N/AMaintains
2 years ago
Ati Physical Therapy IncATIP
1Buy$14.00N/AInitiates Coverage On
4 years ago
Pharmerica CorpPMC
1SellN/AN/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.